Abstract:The human intestinal proton-coupled oligopeptide transporter hPEPT1 has been implicated in the absorption of pharmacologically active compounds. We have investigated the interactions between a comprehensive selection of drugs, and wild-type and variant hPEPT1s expressed in Xenopus oocytes, using radiotracer uptake and electrophysiological methods. The beta-lactam antibiotics ampicillin, amoxicillin, cephalexin and cefadroxil, the antineoplastics delta-aminolevulinic acid (delta-ALA) and bestatin, and the neuropeptide N-acetyl-Asp-Glu (NAAG), were transported, as judged by their ability to evoke inward currents. When the drugs were added in the presence of the typical substrate glycylsarcosine (Gly-Sar), the inward currents were equal or less than that induced by Gly-Sar alone. This suggests that the drugs are transported at a lower turnover rate than Gly-Sar, but may also point towards complex interactions between dipeptides, drugs and the transporter. Gly-Sar and the drugs also modified the kinetics of hPEPT1 presteady-state charge movement, by causing a reduction in maximum charge (Qmax) and a shift of the midpoint voltage (V0.5) to more negative potentials. Our results indicate that the substrate selectivity of hPEPT1 is: Gly-Sar > NAAG, delta-ALA, bestatin > cefadroxil, cephalexin > ampicillin, amoxicillin. Based on steady-state and presteady-state analysis of Gly-Sar and cefadroxil transport, we proposed an extension of the 6-state kinetic model for hPEPT1 function that globally accounts for the observed presteady-state and steady-state kinetics of neutral dipeptide and drug transport. Our model suggests that, under saturating conditions, the rate-limiting step of the hPEPT1 transport cycle is the reorientation of the empty carrier within the membrane. Variations in rates of drug cotransport are predicted to be due to differences in affinity and turnover rate. Oral availability of drugs may be reduced in the presence of physiological concentrations of dietary dipeptides in the gut, suggesting that oral delivery drugs should be taken on an empty stomach. The common hPEPT1 single-nucleotide polymorphisms Ser117Asn and Gly419Ala retained the essential kinetic and drug recognition characteristics of the wild type, suggesting that neither variant is likely to have a major impact on oral absorption of drugs.

Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2

Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2

A Protective Role of Glibenclamide in Inflammation-Associated Injury

Effect of glibenclamide on thyroid hormone metabolism in rats

OATP1B3 (699G>A) and CYP2C92, 3 significantly influenced the transport and metabolism of glibenclamide and glipizide

Characterization of the binding sites for [3H]glibenclamide in rat liver membranes

Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1

The Antidiabetic Agent Glibenclamide Protects Airway Hyperresponsiveness and Inflammation in Mice.

CYP2C9 and OATP1B1 Genetic Polymorphisms Affect the Metabolism and Transport of Glimepiride and Gliclazide.

Effects of 2-Deoxy-D-Glucose on Insulin-Secretory Responses to Intravenous Glucose, Glucagon, Tolbutamide and Arginine in Man

Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants

Inhibitors of GlyT1 and GlyT2 differentially modulate inhibitory transmission.

Combined Contributions of Impaired Hepatic CYP2C11 and Intestinal Breast Cancer Resistance Protein Activities and Expression to Increased Oral Glibenclamide Exposure in Rats with Streptozotocin-Induced Diabetes Mellitus

Different effects of two dipeptidyl peptidase-4 inhibitors and glimepiride on β-cell function in a newly designed two-step hyperglycemic clamp.

Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents

Glibenclamide Decreases ATP-Induced Intracellular Calcium Transient Elevation Via Inhibiting Reactive Oxygen Species and Mitochondrial Activity in Macrophages

Effects of insulin and glucose on renal phosphate reabsorption: interactions with dietary phosphate.

Dependence of glucose transport on autophagy and GAPDH activity

Effects on Conformational States of the Rabbit Sodium/glucose Cotransporter Through Modulation of Polarity and Charge at Glutamine 457.

Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier

Effect of glycyrrhetinic acid C-18 epimerides on membrane transport of P-gp substrate rhodamine 123 in Caco-2 cell monolayers